Trial
NCT03344341
A Phase IV Study in Drug-Naive Patients With T2DM in China
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
AstraZeneca
Collaborators
—
Condition
Type 2 Diabetes Mellitus
Intervention
Dapagliflozin
Why stopped
Study overall progress behind of scheduled timeline. Study was terminated early due to company decision.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-12-07